NCT03943368 is a NA clinical trial of Ceevra Reveal in Prostate Cancer, sponsored by Ceevra, Inc..

Who is sponsoring NCT03943368?

NCT03943368 is sponsored by Ceevra, Inc..

What drugs are being tested in NCT03943368?

Interventions in NCT03943368: Ceevra Reveal.

What condition does NCT03943368 study?

NCT03943368 studies Prostate Cancer.

Is NCT03943368 still recruiting?

NCT03943368 is currently completed. Last updated 4 June 2024.

Last reviewed 2024-06-04 · How we verify

NCT03943368

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Virtual Reality (VR) Models for Robotic Prostatectomy

Completed NA Last updated 4 June 2024

What this trial tests

NA trial testing Ceevra Reveal in Prostate Cancer in 92 participants. Completed in 30 September 2023.

Timeline

1 January 2019

Primary endpoint
30 September 2023

30 September 2023

Quick facts

Lead sponsor	Ceevra, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	92
Start date	1 January 2019
Primary completion	30 September 2023
Estimated completion	30 September 2023
Sites	6 locations across United States

Drugs / interventions tested

Ceevra Reveal

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Ceevra, Inc.

Who can join

18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic prostatectomy) and improved patient care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Prostatectomy on Trifecta Outcomes: A Randomized Clinical Trial.
Shirk JD, Reiter R, Wallen EM, Pak R, et al · · 2022 · cited 24× · PMID 35848770 · DOI 10.1097/ju.0000000000002719
Trifecta Outcomes After Use of 3-Dimensional Digital Models for Planning of Robotic Prostatectomy: A Secondary Analysis of a Randomized Clinical Trial.
Shirk JD, Reiter RE, Wallen EM, Pak RW, et al · · 2024 · cited 2× · PMID 39283633 · DOI 10.1001/jamanetworkopen.2024.34143

Verify or expand the search:

Other trials of Ceevra Reveal

Trials testing the same drug.

NCT03870269 — Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC · NA · completed
NCT03334344 — Using Virtual Reality (VR) Models for Preoperative Planning · NA · completed

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Ceevra, Inc. trials

Trials by the same sponsor.

NCT03870269 — Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC · NA · completed
NCT03334344 — Using Virtual Reality (VR) Models for Preoperative Planning · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03943368 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ceevra, Inc.
Last refreshed: 4 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03943368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing